PMC:7243768 / 62376-62562 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2393","span":{"begin":10,"end":18},"obj":"Species"},{"id":"2395","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"2396","span":{"begin":30,"end":40},"obj":"Chemical"},{"id":"2406","span":{"begin":89,"end":95},"obj":"Disease"},{"id":"2407","span":{"begin":97,"end":109},"obj":"Disease"},{"id":"2408","span":{"begin":111,"end":125},"obj":"Disease"},{"id":"2409","span":{"begin":168,"end":179},"obj":"Disease"}],"attributes":[{"id":"A2393","pred":"tao:has_database_id","subj":"2393","obj":"Tax:694009"},{"id":"A2395","pred":"tao:has_database_id","subj":"2395","obj":"MESH:D012254"},{"id":"A2396","pred":"tao:has_database_id","subj":"2396","obj":"MESH:D009705"},{"id":"A2406","pred":"tao:has_database_id","subj":"2406","obj":"MESH:D000740"},{"id":"A2407","pred":"tao:has_database_id","subj":"2407","obj":"MESH:D006996"},{"id":"A2408","pred":"tao:has_database_id","subj":"2408","obj":"MESH:C537153"},{"id":"A2409","pred":"tao:has_database_id","subj":"2409","obj":"MESH:D001919"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T718","span":{"begin":10,"end":18},"obj":"Disease"},{"id":"T719","span":{"begin":10,"end":14},"obj":"Disease"},{"id":"T720","span":{"begin":89,"end":95},"obj":"Disease"},{"id":"T721","span":{"begin":97,"end":109},"obj":"Disease"},{"id":"T722","span":{"begin":111,"end":125},"obj":"Disease"}],"attributes":[{"id":"A718","pred":"mondo_id","subj":"T718","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A719","pred":"mondo_id","subj":"T719","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A720","pred":"mondo_id","subj":"T720","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A721","pred":"mondo_id","subj":"T721","obj":"http://purl.obolibrary.org/obo/MONDO_0018543"},{"id":"A722","pred":"mondo_id","subj":"T722","obj":"http://purl.obolibrary.org/obo/MONDO_0018100"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T69397","span":{"begin":30,"end":40},"obj":"Chemical"}],"attributes":[{"id":"A28903","pred":"chebi_id","subj":"T69397","obj":"http://purl.obolibrary.org/obo/CHEBI_33838"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T122","span":{"begin":50,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0045071"},{"id":"T123","span":{"begin":63,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0019079"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T451","span":{"begin":0,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T280","span":{"begin":89,"end":95},"obj":"Phenotype"},{"id":"T281","span":{"begin":97,"end":109},"obj":"Phenotype"},{"id":"T282","span":{"begin":111,"end":125},"obj":"Phenotype"},{"id":"T283","span":{"begin":168,"end":179},"obj":"Phenotype"}],"attributes":[{"id":"A280","pred":"hp_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/HP_0001903"},{"id":"A281","pred":"hp_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/HP_0002901"},{"id":"A282","pred":"hp_id","subj":"T282","obj":"http://purl.obolibrary.org/obo/HP_0002917"},{"id":"A283","pred":"hp_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/HP_0001662"}],"text":"Ribavirin SARS-CoV Anti-viral nucleoside analog – inhibits the viral genomic replication Anemia, hypocalcemia, hypomagnesemia, developed the risk of teratogenicity and bradycardia [118]."}